The pharmaceutical giant Solvay Pharmaceuticals is unapologetic about its actions aimed at maintaining its monopoly on the phamaceutical testosterone gel Androgel (an anabolic-androgenic steroid).* Solvay has “bought off” generic companies who planned to introduce inexpensive, generic versions of Androgel. The generic companies Watson Pharmaceuticals, Par Pharmaceutical, and Paddock Laboratories were prepared to offer a cheap [...]
thinksteroids.com
Big Pharma Wants Monopoly on Anabolic Steroid Sales in the United States - MESO-Rx
The pharmaceutical giant Solvay Pharmaceuticals is unapologetic about its actions aimed at maintaining its monopoly on the phamaceutical testosterone gel
thinksteroids.com
